| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/23/2005 | CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1599627A Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 03/23/2005 | CN1599626A Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 03/23/2005 | CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1599613A Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2005 | CN1599612A Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 03/23/2005 | CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 03/23/2005 | CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid |
| 03/23/2005 | CN1599609A Combination of a selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/23/2005 | CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same |
| 03/23/2005 | CN1599601A Plaster for the treatment of dysfunctions and disorders of nails |
| 03/23/2005 | CN1599564A Oral immunostimulation of mammals, birds, fish and reptiles from 1-4 linked ss-d-mannuronic acid |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1596981A Composition of nanometer SOD and pueraria root or its extract and its preparation method |
| 03/23/2005 | CN1596975A Composition of nanometer SOD and animal medicine or its extract and its preparation method |
| 03/23/2005 | CN1596970A Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
| 03/23/2005 | CN1596951A Phellodendron bark disperse tablet and its preparation method |
| 03/23/2005 | CN1194092C Medusa cystatin Protease inhibitor gene, and expression and use therof |
| 03/23/2005 | CN1194090C Growth factor and genetic sequence for encoding same |
| 03/23/2005 | CN1194086C Preparing method method of neural stem cell preparation, |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/23/2005 | CN1194002C Shortened-chain polynucleotide and process for the preparation thereof |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193765C Use of 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-one-4H-1 benzopyrany 1-7-hydroxy-beta-D-glucuronic acid in producing medicine |
| 03/23/2005 | CN1193743C Multilayer pharmaceutical product for release in the colon |
| 03/22/2005 | US6871171 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869970 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869944 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869926 Comprises amylin/adrenomedullin which stimulates chondrocyte proliferation; for treatment of cartilage disorders/bone growth disorders |
| 03/22/2005 | US6869615 Enterically coated to prevent gastrointestinal side effects |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/22/2005 | CA2178219C Substituted morpholine derivatives and their use as therapeutic agents |
| 03/17/2005 | WO2005024004A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023287A1 Skin ulcer preventive curative agent containing human recombinant hgf |
| 03/17/2005 | WO2005023248A1 TGF-β GENE EXPRESSION INHIBITOR |
| 03/17/2005 | WO2005023235A1 Benzyl alcohol derivatives or salts thereof |
| 03/17/2005 | WO2005004838A8 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 03/17/2005 | WO2005002563A3 Method for treating alcoholic hepatitis |
| 03/17/2005 | WO2004113378A3 Control of lactation and peptides therefore |
| 03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2002079193A8 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
| 03/17/2005 | US20050059725 Treating schizophrenia or Parkinson's disease with thiolutin dioxide |
| 03/17/2005 | US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example |
| 03/17/2005 | US20050059720 Medicinal compositions for the prevention or treatment of cardiac failure |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling |
| 03/17/2005 | US20050059679 Novel hexacyclic compounds |
| 03/17/2005 | US20050059675 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 03/17/2005 | US20050059674 reducing granulation tissue in humans having otitis and an open tympanic membrane comprising topically applying an aqueous suspension composition containing a combination of ciprofloxacin and dexamethasone |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059627 Administering antisense oligonucleotides against the mRNA of corticotropin releasing factor subtype-2 (CRF2) receptor; treating anxiety, obsessive-compulsive disorder, panic disorders, post-traumatic stress, phobias and depression |
| 03/17/2005 | US20050059626 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059614 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
| 03/17/2005 | US20050059608 Pharmaceutical compounds |
| 03/17/2005 | US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases |
| 03/17/2005 | US20050059600 Chimeric natriuretic peptides |
| 03/17/2005 | US20050059594 Administering macrophage derived factor; oncomodulin |
| 03/17/2005 | US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059092 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders |
| 03/17/2005 | US20050059010 Macular degeneration diagnostics and therapeutics |